{"schema":"hottub-news/prospects/v1","item":{"id":"n_hojs47bjevc2mnge37ga","title":"La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1","title_en":null,"url":"https://www.diariodesevilla.es/salud/fda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html","outlet":"Diario de Sevilla","published":"2026-11-12T06:01:00Z","sponsored":false,"page":"https://hottub.news/articles/n_hojs47bjevc2mnge37ga"},"prospects":[{"name":"Diario de Sevilla","kind":"organization","role":"outlet","website":"https://diariodesevilla.es/","entity":"wikidata:Q3026338","source":"https://www.diariodesevilla.es/salud/fda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html","note":"Published: La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1 (2026-11-12)","reason":"Published “La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1” on 2026-11-12","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=Diario%20de%20Sevilla&kind=organization&website=https%3A%2F%2Fdiariodesevilla.es%2F&source=https%3A%2F%2Fwww.diariodesevilla.es%2Fsalud%2Ffda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html&entity=wikidata%3AQ3026338&note=Published%3A%20La%20FDA%20alerta%20sobre%20un%20posible%20riesgo%20de%20desarrollar%20neuropat%C3%ADa%20%C3%B3ptica%20isqu%C3%A9mica%20asociado%20a%20los%20medicamentos%20GLP-1%20%282026-11-12%29","propose":{"name":"Diario de Sevilla","kind":"organization","reason":"Published “La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1” on 2026-11-12","requestId":"news:n_hojs47bjevc2mnge37ga:wikidata:Q3026338:acda0a84","website":"https://diariodesevilla.es/","sourceUrl":"https://www.diariodesevilla.es/salud/fda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html","entity":"wikidata:Q3026338"}}],"someone_else":{"source":"https://www.diariodesevilla.es/salud/fda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html","note":"In the news: La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1 (Diario de Sevilla, 2026-11-12)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}